ArticleInvestigational new drugs2021

Early administration of amatuximab, a chimeric high-affinity anti-mesothelin monoclonal antibody, suppresses liver metastasis of mesothelin-expressing pancreatic cancer cells and enhances gemcitabine sensitivity in a xenograft mouse model.

Yuki Fujii et al.PubMed ↗Publisher ↗

No numbers read from the abstract.